HEMOSTASIS VALVE MARKET ANALYSIS (2020-2027) - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

HEMOSTASIS VALVE MARKET ANALYSIS (2020-2027)

Description:

Read here the market research report on the “Hemostasis Valve Market” published by CMI team – PowerPoint PPT presentation

Number of Views:10
Date added: 30 October 2020
Slides: 16
Provided by: kunalbhuta
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: HEMOSTASIS VALVE MARKET ANALYSIS (2020-2027)


1
  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • COVID-19 Impact Tracker

2
HEMOSTASIS VALVE MARKET ANALYSIS (2020-2027)
  • Hemostasis Valve Market, by Type (Y-connectors
    Hemostasis Valves, Double Y-connector Hemostasis
    Valves and One-handed Hemostasis Valves), by
    Applications (Hemophilia, Von Willebrand Disease,
    and Other Applications), by End Users (Hospitals,
    Clinics, Ambulatory Surgical Centers, and Other
    End Users), and by Region (North America, Latin
    America, Europe, Middle East, Asia Pacific, and
    Africa) - Size, Share, Outlook, and Opportunity
    Analysis, 2020 - 2027

3
  • Hemostasis is a physiological process to prevent
    and stop bleeding. Hemostasis involves three
    steps, which include vascular spasm
    (vasoconstriction), platelet plug formation, and
    coagulation. Some people are born with blood
    disorder disease (inherited diseases) such as
    Hemophilia and Von Willebrand disease.
     Hemophilia is a condition in which, blood does
    not clot properly due to lack of sufficient
    blood-clotting proteins (clotting factors), while
    Von Willebrand disease is caused due to the
    missing or defective clotting protein (von
    Willebrand factor).
  • Hemostasis valve is a device that is used to
    reduce risk of thromboembolism during
    neuroendovascular procedures. Guardian hemostasis
    valve is manufactured by Vascular Solutions Inc.
    and WATCHDOG hemostasis valve is manufactured by
    Boston Scientific Corporation are some examples
    of hemostasis valve. Moreover, hemostasis valve
    maximizes safety of the patient, reduces risk of
    air embolism, and blood loss.

4
Global Hemostasis Valve Market Drivers
  • The global hemostasis valve market growth is
    expected to surge over the forecast period, owing
    to increasing technological advances in
    hemostasis valves by manufactures. For instance,
    in 2017, new hemostasis valves HyperSeal and
    CertuSeal valves for the interventional and
    diagnostic catheters were introduced by the
    Freudenberg Medical. Additionally, Freudenberg
    Medical had introduced innovative FlexSeal valve
    in 2016. Moreover, for large bore procedure,
    Freudenberg Medical had introduced new HyperSeal
    Introducer Sheath with hydrophilic coating.

5
Global Hemostasis Valve Market Drivers
  • Furthermore, in May 2019, PhD (Push, Hold, and
    Deliver), which is a polycarbonate hemostasis
    control valve was launched by Merit Medical
    Systems, Inc. In addition, to operate the valve
    with one hand as well as to remove the diagnostic
    or interventional devices, PhD polycarbonate
    hemostasis control valve is used. Moreover,
    dual-seal PhD device is used to minimize the loss
    of blood without restricting device movement, and
    allows pressure injections up to 400 psi. These
    factors are expected to support global hemostasis
    valve market growth over the forecast period.

6
  • Global Hemostasis Valve Market Restraints
  • However, risk associated with the hemostasis
    valve such as air leakage that can cause air
    embolism is one of the major factors, which is
    expected to hamper growth of the global
    hemostasis valve market. For instance, in 2016,
    the U.S. Food and Drug Administration (FDA)
    recalled Guardian II Hemostasis Valves,
    manufactured by Vascular Solutions, Inc. This
    recall of Guardian II Hemostasis Valves was due
    to increased risk of air leakage that may cause
    an air embolism. Moreover, according to the U.S.
    FDA, the healthcare professional who have faced
    the problem of air leakage, should remove the
    product (Guardian II Hemostasis Valves) from
    their inventory and return them to vascular
    solution.  

7
  • Global Hemostasis Valve Market Regional Analysis
  • North America is expected to account for largest
    market share in global hemostasis valve market,
    owing to factors such as increasing presence of
    key players and their involvement in the
    innovation associated with the hemostasis valve.
    For instance, in 2017, Qosina added four new
    Y-connecter hemostasis valve to its product line.
    Y-connector helps healthcare professional to
    handle hemostasis valve comfortably. 
  • Growing prevalence of blood disorder disease is
    another factor that is expected to drive
    hemostasis valve market growth in North America.
    For instance, according to the Centers for
    Disease Control and Prevention (CDC), in 2019, in
    the U.S., the number of patient suffering from
    the hemophilia was estimated around 20,000, based
    on the expected death and birth since 1994.
    Moreover, according to the same source, most of
    the patient suffering from hemophilia were
    diagnosed at young age only.

8
  • Global Hemostasis Valve Market Regional Analysis
  • Europe is expected to exhibit highest CAGR over
    the forecast period due to increasing prevalence
    of hemophilia, which is a blood related genetic
    disorder. For instance, in 2018, according to
    WHO, in U.K., around 6,000 people suffered from
    hemophilia. In addition, according to the same
    source, in 2018, around 5,400 people suffered
    from hemophilia A while 1,100 people suffered
    from hemophilia B.

9
  • Global Hemostasis Valve Market Key Players
  • Key players operating in the global hemostasis
    valve market include Freudenberg Medical, LLC,
    Teleflex Incorporated, Boston Scientific
    Corporation, Argon Medical Devices., B. Braun
    Melsungen AG, Isla Lab Products LLC, SCW Medicath
    Ltd, Shenzhen Antmed Co.,Ltd., Galt Medical
    Corp., and Abbott Laboratories.

10
  • Market Taxonomy
  • On the basis of type, the global hemostasis valve
    market is segmented into
  • Y-connectors Hemostasis Valves
  • Double Y-connector Hemostasis Valves
  • One-handed Hemostasis Valves
  • Others
  • On the basis of applications, the global
    hemostasis valve market is segmented into
  • Hemophilia
  • Von Willebrand Disease

11
  • On the basis of end user, the global hemostasis
    valve market is segmented into
  • Hospital
  • Clinics
  • Ambulatory Surgical Centers
  • Others End Users
  • On the basis of region, the global hemostasis
    valve market is segmented into
  • North America
  • Latin America
  • Europe
  • Middle East
  • Asia Pacific
  • Africa

12
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Buy Now
  • Referencehttps//www.coherentmarketinsights.com/o
    ngoing-insight/hemostasis-valve-market-4123

13
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

14
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
    U.S.
  • Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

15
  • Thank You!
  • Kindly follow CMI Social Media
    Profiles for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com